Literature DB >> 34179564

Role of Enteroendocrine Hormones in Appetite and Glycemia.

Maria Laura Ricardo-Silgado1, Alison McRae1, Andres Acosta1.   

Abstract

Enteroendocrine cells (EECs) are specialized cells that are widely distributed throughout the gastrointestinal tract. EECs sense luminal content and release hormones, such as: ghrelin, cholecystokinin, glucagon like peptide 1, peptide YY, insulin like peptide 5, and oxyntomodulin. These hormones can enter the circulation to act on distant targets or act locally on neighboring cells and neuronal pathways to modulate food digestion, food intake, energy balance and body weight. Obesity, insulin resistance and diabetes are associated with alterations in the levels of enteroendocrine hormones. Evidence also suggests that modified regulation and release of gut hormones are the result of compensatory mechanisms in states of excess adipose tissue and hyperglycemia. This review collects the evidence available detailing pathophysiological alterations in enteroendocrine hormones and their association with appetite, obesity and glycemic control.

Entities:  

Keywords:  Appetite; Diabetes; Enteroendocrine hormones; Obesity

Year:  2021        PMID: 34179564      PMCID: PMC8224828          DOI: 10.1016/j.obmed.2021.100332

Source DB:  PubMed          Journal:  Obes Med        ISSN: 2451-8476


  73 in total

1.  Cholecystokinin is up-regulated in obese mouse islets and expands beta-cell mass by increasing beta-cell survival.

Authors:  Jeremy A Lavine; Philipp W Raess; Donald S Stapleton; Mary E Rabaglia; Joshua I Suhonen; Kathryn L Schueler; James E Koltes; John A Dawson; Brian S Yandell; Linda C Samuelson; Margery C Beinfeld; Dawn Belt Davis; Marc K Hellerstein; Mark P Keller; Alan D Attie
Journal:  Endocrinology       Date:  2010-06-09       Impact factor: 4.736

2.  Intravenous CCK-8, but not GLP-1, suppresses ghrelin and stimulates PYY release in healthy men.

Authors:  Ixchel M Brennan; Bärbel Otto; Kate L Feltrin; James H Meyer; Michael Horowitz; Christine Feinle-Bisset
Journal:  Peptides       Date:  2006-11-28       Impact factor: 3.750

3.  Mechanisms, Pathophysiology, and Management of Obesity.

Authors:  Steven B Heymsfield; Thomas A Wadden
Journal:  N Engl J Med       Date:  2017-04-13       Impact factor: 91.245

4.  Effects of fat, protein, and carbohydrate and protein load on appetite, plasma cholecystokinin, peptide YY, and ghrelin, and energy intake in lean and obese men.

Authors:  Ixchel M Brennan; Natalie D Luscombe-Marsh; Radhika V Seimon; Bärbel Otto; Michael Horowitz; Judith M Wishart; Christine Feinle-Bisset
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-05-03       Impact factor: 4.052

Review 5.  Diabetes, hypertension, and chronic kidney disease progression: role of DPP4.

Authors:  Ravi Nistala; Virginia Savin
Journal:  Am J Physiol Renal Physiol       Date:  2017-01-25

6.  Insulin and norepinephrine regulate ghrelin secretion from a rat primary stomach cell culture.

Authors:  Jeffrey Gagnon; Younes Anini
Journal:  Endocrinology       Date:  2012-06-12       Impact factor: 4.736

Review 7.  Glucagon-like peptide-1, glucagon-like peptide-2, and lipid metabolism.

Authors:  Thomas A Lutz; Elena Osto
Journal:  Curr Opin Lipidol       Date:  2016-06       Impact factor: 4.776

8.  GLP-1 Analog Modulates Appetite, Taste Preference, Gut Hormones, and Regional Body Fat Stores in Adults with Obesity.

Authors:  Hoda Kadouh; Victor Chedid; Houssam Halawi; Duane D Burton; Matthew M Clark; Disha Khemani; Adrian Vella; Andres Acosta; Michael Camilleri
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

9.  Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the glucagon-like peptide 1 (GLP-1) receptor agonist exenatide twice daily or other glucose-lowering therapies: a retrospective analysis of the LifeLink database.

Authors:  Jennie H Best; Byron J Hoogwerf; William H Herman; Elise M Pelletier; Daniel B Smith; Made Wenten; Mohamed A Hussein
Journal:  Diabetes Care       Date:  2010-10-07       Impact factor: 19.112

10.  Diet-induced gene expression of isolated pancreatic islets from a polygenic mouse model of the metabolic syndrome.

Authors:  T Dreja; Z Jovanovic; A Rasche; R Kluge; R Herwig; Y C L Tung; H G Joost; G S H Yeo; H Al-Hasani
Journal:  Diabetologia       Date:  2009-11-10       Impact factor: 10.122

View more
  1 in total

Review 1.  The significance and potential of functional food ingredients for control appetite and food intake.

Authors:  Mina Esmaeili; Marjan Ajami; Meisam Barati; Fardin Javanmardi; Anahita Houshiarrad; Amin Mousavi Khaneghah
Journal:  Food Sci Nutr       Date:  2022-02-18       Impact factor: 3.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.